Coronavirus vaccine: Sinopharm ramps up production as China approves jab for use on general public | South China Morning Post

The Chinese state-owned drug maker Sinopharm has been ramping up mass production of its Covid-19 vaccines, according to state media reports. The Sinopharm jab is China’s first home-grown vaccine against the coronavirus. On December 31, 2020, Beijing approved its use on members of the general public as officials prom…

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.